AMGEN INC (AMGN) › Cash & EquivalentsAMGEN INC (AMGN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2006: $1.28B2007: $2.02B2008: $1.77B2009: $2.88B2010: $3.29B2011: $6.95B2012: $3.26B2013: $3.81B2014: $3.73B2015: $4.14B2016: $3.24B2017: $3.80B2018: $6.95B2019: $6.04B2020: $6.27B2021: $7.99B2022: $7.63B2023: $10.94B2024: $11.97B2025: $9.13B$9.13B2006Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$9.13B-23.8%2024$11.97B+9.4%2023$10.94B+43.5%2022$7.63B-4.5%2021$7.99B+27.5%2020$6.27B+3.8%2019$6.04B-13.1%2018$6.95B+82.8%2017$3.80B+17.2%2016$3.24B-21.8%2015$4.14B+11.1%2014$3.73B-1.9%2013$3.81B+16.8%2012$3.26B-53.1%2011$6.95B+111.3%2010$3.29B+14.0%2009$2.88B+62.6%2008$1.77B-12.4%2007$2.02B+57.8%2006$1.28B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share